Peringatan Keamanan

GBCAs cross the human placenta and result in fetal exposure and gadolinium retention. The human data on the association between GBCAs and adverse fetal outcomes are limited and inconclusive. In animal reproduction studies, no adverse fetal effects were observed with the administration of gadodiamide to pregnant rats during organogenesis at doses 1.3 times the maximum human dose based on body surface area. Because of the potential risks of gadolinium to the fetus, use gadodiamide only if imaging is essential during pregnancy and cannot be delayed.L49881

Clinical consequences of overdose with gadodiamide have not been reported. The minimum lethal dose of intravenously administered gadodiamide in rats and mice is greater than 20 mmol/kg (200 times the recommended human dose of 0.1 mmol/kg; 67 times the cumulative 0.3 mmol/kg dose). Gadodiamide is dialyzable.L49881

Long-term animal studies have not been performed to evaluate the carcinogenic potential of gadodiamide. The results of the following genotoxicity assays were negative: in vitro bacterial reverse mutation assay, in vitro Chinese Hamster Ovary (CHO)/Hypoxanthine Guanine Phosphoribosyl Transferase (HGPT) forward mutation assay, in vitro CHO chromosome aberration assay, and the in vivo mouse micronucleus assay at intravenous doses of 27 mmol/kg (approximately 7 times the maximum human dose based on a body surface area comparison). Impairment of male or female fertility was not observed in rats after intravenous administration three times per week at the maximum dose tested of 1.0 mmol/kg (approximately 0.5 times the maximum human dose based on a body surface area comparison).L49881

Gadodiamide

DB00225

small molecule approved investigational

Deskripsi

Gadodiamide is a linear, non-ionic gadolinium-based contrast agent (GBCA) that is used in magnetic resonance imaging (MRI) procedures to assist in the visualization of blood vessels.A263086,A263091 GBCAs constitute the largest group of MR agents, and they are thought to be safer than nonionic iodinated contrast agents.A263096 Approved by the FDA in 1993, gadodiamide is the first non-ionic GBCA to be used.A263101 However, since linear, non-ionic GBCA is less stable than macrocyclic or ionic GBCA, gadodiamide can potentially lead to more gadolinium retention in the brain and thus more likely to cause side effects.A263106

Struktur Molekul 2D

Berat 573.66
Wujud liquid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) The mean distribution and elimination half-lives (reported as mean ± SD) were calculated to be of 3.7 ± 2.7 minutes and 77.8 ± 16 minutes, respectively.[L49881]
Volume Distribusi The volume of distribution of gadodiamide (200 ± 61 mL/kg) is equivalent to that of extracellular water. Following GBCA administration, gadolinium is present for months or years in the brain, bone, skin, and other organs.[L49881]
Klirens (Clearance) The renal and plasma clearance rates of gadodiamide are nearly identical (1.7 and 1.8 mL/min/kg, respectively), and are similar to that of substances excreted primarily by glomerular filtration.[L49881]

Absorpsi

The pharmacokinetics of intravenously administered gadodiamide in normal subjects conforms to an open, two-compartment model.L49881

Metabolisme

There is no detectable biotransformation or decomposition of gadodiamide.

Rute Eliminasi

Gadodiamide is eliminated primarily in the urine with 95.4 ± 5.5% (mean ± SD) of the administered dose eliminated by 24 hours.L49881

Interaksi Obat

727 Data
Cyclosporine Cyclosporine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Icosapent Icosapent may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefotiam Cefotiam may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Mesalazine Mesalazine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefmenoxime Cefmenoxime may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefmetazole Cefmetazole may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Pamidronic acid Pamidronic acid may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Tenofovir disoproxil Tenofovir disoproxil may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Indomethacin Indomethacin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cidofovir Cidofovir may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefpiramide Cefpiramide may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Ceftazidime Ceftazidime may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Loracarbef Loracarbef may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefalotin Cefalotin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Nabumetone Nabumetone may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Ketorolac Ketorolac may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Tenoxicam Tenoxicam may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Celecoxib Celecoxib may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefotaxime Cefotaxime may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Tolmetin Tolmetin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Foscarnet Foscarnet may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Rofecoxib Rofecoxib may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Piroxicam Piroxicam may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Methotrexate Methotrexate may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cephalexin Cephalexin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Fenoprofen Fenoprofen may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Valaciclovir Valaciclovir may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Valdecoxib Valdecoxib may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Diclofenac Diclofenac may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Sulindac Sulindac may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Bacitracin Bacitracin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Amphotericin B Amphotericin B may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cephaloglycin Cephaloglycin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Flurbiprofen Flurbiprofen may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Adefovir dipivoxil Adefovir dipivoxil may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Pentamidine Pentamidine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Etodolac Etodolac may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Mefenamic acid Mefenamic acid may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Acyclovir Acyclovir may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Naproxen Naproxen may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Sulfasalazine Sulfasalazine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Phenylbutazone Phenylbutazone may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Meloxicam Meloxicam may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Carprofen Carprofen may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefaclor Cefaclor may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Diflunisal Diflunisal may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Tacrolimus Tacrolimus may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Ceforanide Ceforanide may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Salicylic acid Salicylic acid may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Meclofenamic acid Meclofenamic acid may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Acetylsalicylic acid Acetylsalicylic acid may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Carboplatin Carboplatin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Oxaprozin Oxaprozin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Ketoprofen Ketoprofen may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Balsalazide Balsalazide may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Ibuprofen Ibuprofen may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefditoren Cefditoren may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Atazanavir Atazanavir may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Colistimethate Colistimethate may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefuroxime Cefuroxime may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefapirin Cefapirin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefadroxil Cefadroxil may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefprozil Cefprozil may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Ceftriaxone Ceftriaxone may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Olsalazine Olsalazine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Lumiracoxib Lumiracoxib may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefamandole Cefamandole may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefazolin Cefazolin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefonicid Cefonicid may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefoperazone Cefoperazone may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefotetan Cefotetan may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefoxitin Cefoxitin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Ceftizoxime Ceftizoxime may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefradine Cefradine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Magnesium salicylate Magnesium salicylate may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Salsalate Salsalate may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Choline magnesium trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefepime Cefepime may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefacetrile Cefacetrile may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Ceftibuten Ceftibuten may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cefpodoxime Cefpodoxime may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Antrafenine Antrafenine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Aminophenazone Aminophenazone may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Antipyrine Antipyrine may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Tiaprofenic acid Tiaprofenic acid may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Lopinavir Lopinavir may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Etoricoxib Etoricoxib may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Hydrolyzed Cephalothin Hydrolyzed Cephalothin may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cephalothin Group Cephalothin Group may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Oxyphenbutazone Oxyphenbutazone may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Latamoxef Latamoxef may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Nimesulide Nimesulide may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Benoxaprofen Benoxaprofen may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Metamizole Metamizole may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Zomepirac Zomepirac may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Ceftobiprole Ceftobiprole may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Cimicoxib Cimicoxib may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Ceftaroline fosamil Ceftaroline fosamil may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Lornoxicam Lornoxicam may decrease the excretion rate of Gadodiamide which could result in a higher serum level.
Aceclofenac Aceclofenac may decrease the excretion rate of Gadodiamide which could result in a higher serum level.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 30307671
    Ichikawa S, Omiya Y, Onishi H, Motosugi U: Linear gadolinium-based contrast agent (gadodiamide and gadopentetate dimeglumine)-induced high signal intensity on unenhanced T(1) -weighted images in pediatric patients. J Magn Reson Imaging. 2019 Apr;49(4):1046-1052. doi: 10.1002/jmri.26311. Epub 2018 Oct 11.
  • PMID: 8880714
    Aslanian V, Lemaignen H, Bunouf P, Svaland MG, Borseth A, Lundby B: Evaluation of the clinical safety of gadodiamide injection, a new nonionic MRI contrast medium for the central nervous system: a European perspective. Neuroradiology. 1996 Aug;38(6):537-41. doi: 10.1007/BF00626092.
  • PMID: 10931582
    Runge VM: Safety of approved MR contrast media for intravenous injection. J Magn Reson Imaging. 2000 Aug;12(2):205-13. doi: 10.1002/1522-2586(200008)12:2<205::aid-jmri1>3.0.co;2-p.
  • PMID: 24414380
    Pierre VC, Allen MJ, Caravan P: Contrast agents for MRI: 30+ years and where are we going? J Biol Inorg Chem. 2014 Feb;19(2):127-31. doi: 10.1007/s00775-013-1074-5. Epub 2014 Jan 11.
  • PMID: 26606549
    Robert P, Violas X, Grand S, Lehericy S, Idee JM, Ballet S, Corot C: Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats. Invest Radiol. 2016 Feb;51(2):73-82. doi: 10.1097/RLI.0000000000000241.

Contoh Produk & Brand

Produk: 4 • International brands: 0
Produk
  • Omniscan
    Injection • 287 mg/1mL • Intravenous • US • Approved
  • Omniscan
    Injection • 287 mg/1mL • Intravenous • US • Approved
  • Omniscan
    Solution • 287 mg / mL • Intravenous • Canada • Approved
  • Omniscan Liq IV 287mg/ml
    Liquid • 287 mg / mL • Intravenous • Canada • Approved

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul